by Amanda Morris
A Northwestern University research team potentially has found a safer way to keep blood vessels healthy during and after surgery.
During open-heart procedures, physicians administer large doses of a blood-thinning drug called heparin to prevent clot formation. When given too much heparin, patients can develop complications from excessive bleeding. A common antidote is the compound protamine sulfate, which binds to heparin to reverse its effects.
"Protamine is a natural compound that has been used in surgeries for many decades," said Guillermo Ameer, professor of biomedical engineering at Northwestern's McCormick School of Engineering and surgery at the Feinberg School of Medicine.
But when protamine doses are too large, they can also have an opposite effect—morphing into an anticoagulant that exacerbates the bleeding issues caused by heparin.
Ameer and his team were able to revamp this long-established drug to not only prevent this risky side effect but to use it as a template to deliver nitric oxide, a molecule that plays a vital role in many biological processes and is potentially useful to prevent scarring in vascular grafts and stents.
"Nitric oxide is a very protective molecule for vasculature," said Robert van Lith, a postdoctoral fellow in Ameer's lab. "Normally, all of the cells inside blood vessels constantly secrete this molecule. It prevents the cell overgrowth that contributes to scarring in the blood vessel and keeps the inside of the vessel healthy."
While other nitric oxide-releasing drugs do exist, most become toxic after the gas is expelled. Nitrosamine, for example, has been known to cause cancer. Ameer's team was able to convert protamine into a nitric oxide donor without changing its natural structure. Because protamine already naturally occurs in the body, it did not leave behind toxic byproducts.
"After protamine releases the nitric oxide, it reverts back to its natural form and still works as a heparin antidote," van Lith said. "This is a much safer alternative."
Supported by the American Heart Association, the research is now available online and will be published in the May 2015 issue of Free Radical Biology and Medicine. Van Lith is first author of the paper.
Protamine is needed in many surgeries because the heparin dosing can be tricky. Surgeons must wait to administer protamine until after bleeding issues arise in the operating room, or when normal blood clotting needs to be re-established at the end of the surgery. "It's not super precise as clotting needs to be monitored by surgeons during the surgery," van Lith explained. "And at the end of the surgery, they want to restore normal clotting by neutralizing the remaining heparin."
The research team found that adding nitric oxide does convert protamine into a slightly different molecule but does not affect its function as a heparin antidote. The modified protamine is capable of slowly releasing nitric oxide, preventing both cellular overgrowth and protamine's tendency to become a coagulant at higher doses. Next, the team plans to mix this new drug with a hydrogel that can be applied directly to the outside of an injured blood vessel to provide long-lasting prevention of the cell overgrowth that leads to scarring and obstruction of blood flow.
"We showed we can minimize the negative effects of protamine and turn this widely used drug into a safe nitric oxide generator," Ameer said.
Explore further: Researchers aim to simplify life saving drug
More information: Free Radical Biology and Medicine, http://ift.tt/1IoWOpx
Medical Xpress on facebook
Related Stories
Nanoscience may hold key to surgical recovery
(PhysOrg.com) -- New nano-systems developed in York may eventually help patients recover from surgery without the danger of allergic reactions to drugs.
Nanomolecular binding agents potentially remove anti-coagulant heparin
A University of York scientist's experience in seeing his partner in hospital recovering from a double lung transplant prompted him to design and synthesise new chemical agents that could revolutionise post-operative patient ...
Researchers aim to simplify life saving drug
Heparin, the life saving blood thinner used in major surgeries and treatment of heart diseases, is a complicated drug but a research team from the University of British Columbia has set out to make its use a lot safer by ...
Researchers create synthetic version of heparin for use in kidney patients
Researchers at Rensselaer Polytechnic Institute and the University of North Carolina at Chapel Hill (UNC) have created a synthetic form of low-molecular-weight heparin that can be reversed in cases of overdose and would be ...
New device reduces scarring in damaged blood vessels
When blood vessels are damaged through surgery, it can trigger an endless cycle of scarring and repair.
Recommended for you
Defect found in pancreatic cells could lead to new diabetes treatment
A cellular defect that can impair the body's ability to handle high glucose levels and could point the way to a potential new treatment for diabetes has been identified by Columbia University Medical Center ...
New, natural DNA-based drugs are safe, potent activators of immune system
An experimental single-stranded oligonucleotide-based drug, MGN1703, comprised only of natural DNA components, stimulates the human immune system to fight infections and attack cancer cells without causing ...
Food for thought: Master protein enhances learning and memory
Just as some people seem built to run marathons and have an easier time going for miles without tiring, others are born with a knack for memorizing things, from times tables to trivia facts. These two skills ...
Purging a virus from organ transplants
Human cytomegalovirus (HCMV) is an extremely common virus, which as other members of the herpes virus family causes life-long infections in humans. Most individuals are exposed to HCMV during childhood, yet symptoms can be ...
Researchers track protein 'hitchhiker' in fluorescent worms
Dividing cells—whether they're in an embryo or an adult—rely on the right processes happening at the right time to turn out healthy.
Scientists identify receptor for asthma-associated virus
Scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have identified a cellular receptor for rhinovirus C, a cold-causing virus that is strongly ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
by Amanda Morris
A Northwestern University research team potentially has found a safer way to keep blood vessels healthy during and after surgery.
During open-heart procedures, physicians administer large doses of a blood-thinning drug called heparin to prevent clot formation. When given too much heparin, patients can develop complications from excessive bleeding. A common antidote is the compound protamine sulfate, which binds to heparin to reverse its effects.
"Protamine is a natural compound that has been used in surgeries for many decades," said Guillermo Ameer, professor of biomedical engineering at Northwestern's McCormick School of Engineering and surgery at the Feinberg School of Medicine.
But when protamine doses are too large, they can also have an opposite effect—morphing into an anticoagulant that exacerbates the bleeding issues caused by heparin.
Ameer and his team were able to revamp this long-established drug to not only prevent this risky side effect but to use it as a template to deliver nitric oxide, a molecule that plays a vital role in many biological processes and is potentially useful to prevent scarring in vascular grafts and stents.
"Nitric oxide is a very protective molecule for vasculature," said Robert van Lith, a postdoctoral fellow in Ameer's lab. "Normally, all of the cells inside blood vessels constantly secrete this molecule. It prevents the cell overgrowth that contributes to scarring in the blood vessel and keeps the inside of the vessel healthy."
While other nitric oxide-releasing drugs do exist, most become toxic after the gas is expelled. Nitrosamine, for example, has been known to cause cancer. Ameer's team was able to convert protamine into a nitric oxide donor without changing its natural structure. Because protamine already naturally occurs in the body, it did not leave behind toxic byproducts.
"After protamine releases the nitric oxide, it reverts back to its natural form and still works as a heparin antidote," van Lith said. "This is a much safer alternative."
Supported by the American Heart Association, the research is now available online and will be published in the May 2015 issue of Free Radical Biology and Medicine. Van Lith is first author of the paper.
Protamine is needed in many surgeries because the heparin dosing can be tricky. Surgeons must wait to administer protamine until after bleeding issues arise in the operating room, or when normal blood clotting needs to be re-established at the end of the surgery. "It's not super precise as clotting needs to be monitored by surgeons during the surgery," van Lith explained. "And at the end of the surgery, they want to restore normal clotting by neutralizing the remaining heparin."
The research team found that adding nitric oxide does convert protamine into a slightly different molecule but does not affect its function as a heparin antidote. The modified protamine is capable of slowly releasing nitric oxide, preventing both cellular overgrowth and protamine's tendency to become a coagulant at higher doses. Next, the team plans to mix this new drug with a hydrogel that can be applied directly to the outside of an injured blood vessel to provide long-lasting prevention of the cell overgrowth that leads to scarring and obstruction of blood flow.
"We showed we can minimize the negative effects of protamine and turn this widely used drug into a safe nitric oxide generator," Ameer said.
Explore further: Researchers aim to simplify life saving drug
More information: Free Radical Biology and Medicine, http://ift.tt/1IoWOpx
Medical Xpress on facebook
Related Stories
Nanoscience may hold key to surgical recovery
(PhysOrg.com) -- New nano-systems developed in York may eventually help patients recover from surgery without the danger of allergic reactions to drugs.
Nanomolecular binding agents potentially remove anti-coagulant heparin
A University of York scientist's experience in seeing his partner in hospital recovering from a double lung transplant prompted him to design and synthesise new chemical agents that could revolutionise post-operative patient ...
Researchers aim to simplify life saving drug
Heparin, the life saving blood thinner used in major surgeries and treatment of heart diseases, is a complicated drug but a research team from the University of British Columbia has set out to make its use a lot safer by ...
Researchers create synthetic version of heparin for use in kidney patients
Researchers at Rensselaer Polytechnic Institute and the University of North Carolina at Chapel Hill (UNC) have created a synthetic form of low-molecular-weight heparin that can be reversed in cases of overdose and would be ...
New device reduces scarring in damaged blood vessels
When blood vessels are damaged through surgery, it can trigger an endless cycle of scarring and repair.
Recommended for you
Defect found in pancreatic cells could lead to new diabetes treatment
A cellular defect that can impair the body's ability to handle high glucose levels and could point the way to a potential new treatment for diabetes has been identified by Columbia University Medical Center ...
New, natural DNA-based drugs are safe, potent activators of immune system
An experimental single-stranded oligonucleotide-based drug, MGN1703, comprised only of natural DNA components, stimulates the human immune system to fight infections and attack cancer cells without causing ...
Food for thought: Master protein enhances learning and memory
Just as some people seem built to run marathons and have an easier time going for miles without tiring, others are born with a knack for memorizing things, from times tables to trivia facts. These two skills ...
Purging a virus from organ transplants
Human cytomegalovirus (HCMV) is an extremely common virus, which as other members of the herpes virus family causes life-long infections in humans. Most individuals are exposed to HCMV during childhood, yet symptoms can be ...
Researchers track protein 'hitchhiker' in fluorescent worms
Dividing cells—whether they're in an embryo or an adult—rely on the right processes happening at the right time to turn out healthy.
Scientists identify receptor for asthma-associated virus
Scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have identified a cellular receptor for rhinovirus C, a cold-causing virus that is strongly ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
0 comments:
Post a Comment